Skip to content
MedsAcross

Medicine

Azelastine 3 mg/6 mL injection

Azelastine · Intraocular
Available on requestPrescription onlyUS FDAGeneric name

Azelastine 3 mg/6 mL injection is a generic prescription medicine for intraocular use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Azelastine hydrochloride ophthalmic solution, 0.05% 6 mL container: STORE…

Key facts

Active ingredient (INN)
Azelastine
Brand
Sold under the generic name
Strength
3 mg/6 mL
Dosage form
Injection
Route
Intraocular
Packs
1 bottle of 6 mL and 2 more
Manufacturers
Gland PharmaIndiaSun Pharmaceutical IndustriesIndiaApotexFosun PharmaSandoz
Origin register
US FDA, United States
Storage
Azelastine hydrochloride ophthalmic solution, 0.05% 6 mL container: STORE UPRIGHT between 2° to 25°C (36° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R01AC03 Azelastine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2009
Identifiers
RxCUI 860805DailyMed set ID 6945fb86-27fb-4bab-8908-98772c6269c5, 77a33738-ffcf-221c-1562-780418882e5d, 04e5eede-17ff-4765-af77-d46c139da703 +2NDC 61314-308, 60505-0578, 47335-938 +2Application ANDA202305, ANDA078621, ANDA078738 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, plastic in 1 box / 6 mL in 1 bottle, plastic68083-287-01Gland PharmaIndia25 February 2020
1 bottle, plastic in 1 box / 6 mL in 1 bottle, plastic47335-938-90Sun Pharmaceutical IndustriesIndia31 May 2010
1 bottle, plastic in 1 carton / 6 mL in 1 bottle, plastic60505-0578-4Apotex1 December 2009
1 bottle, plastic in 1 carton / 6 mL in 1 bottle, plastic72266-141-01Fosun Pharma8 September 2020
1 bottle, plastic in 1 carton / 6 mL in 1 bottle, plastic61314-308-02Sandoz21 March 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 November 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Azelastine

Clinical summary

Azelastine is a histamine-1 receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults, among other approved uses. MedsAcross supplies Azelastine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Azelastine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Azelastine 3 mg/6 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.